bioRxiv · 10.1101/2024.07.27.605436
Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits
Abstract
Synaptogyrin-3, a functionally obscure synaptic vesicle protein, interacts with vesicular monoamine and dopamine transporters, bringing together dopamine release and reuptake sites. Synaptogyrin-3 was reduced by chronic cocaine exposure in both humans and rats, and synaptogyrin-3 levels inversely correlated with motivation to take cocaine in rats. Synaptogyrin-3 overexpression in dopamine neurons reduced cocaine self-administration, decreased anxiety-like behavior, and enhanced cognitive flexibility. Overexpression also enhanced nucleus accumbens dopamine signaling and prevented cocaine-induced deficits, suggesting a putative therapeutic role for synaptogyrin-3 in cocaine use disorder.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Peck, E. G., Holleran, K. M., Curry, A. M., Holter, K. M., Estave, P., Sens, J. P., Locke, J., Ortelli, O., George, B., Dawes, M., West, A. M., Alexander, N., Kiraly, D., Farris, S., Gould, R. W., McCool, B., Jones, S. R.. 2024-07-29. Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits. https://doi.org/10.1101/2024.07.27.605436
Cite the original work for its findings. Save a collection to share your selection of sources.